Related Experiment Videos
Collaborative study of bronchial tumour-associated antigens
British Journal of Cancer
|October 1, 1981
Summary
This study compared bronchial tumor-associated antigen preparations and antisera, finding cross-reactivities. After excluding known antigens, five unique antigen-antibody reactions were identified, but their clinical significance remains unknown.
Area of Science:
- Oncology
- Immunology
- Biochemistry
Background:
- Comparative studies of tumor-associated antigens are crucial for diagnostic development.
- Standardization of antigen-antibody assays is essential for reliable results in cancer research.
Purpose of the Study:
- To compare bronchial tumor-associated antigen preparations and antisera submitted by different laboratories.
- To identify unique antigen-antibody reactions relevant to bronchial tumors.
Main Methods:
- Utilized comparative studies involving 21 antigen preparations and 19 antisera.
- Employed absorption procedures and reference antiserum to normal human serum proteins.
- Excluded known antigens like CEA, AFP, NCA, ferritin, lactoferrin, pepsin, gastricsin, SP1, and SP3 using electroimmunoprecipitation.
Main Results:
- Many antisera showed polyspecificity and cross-reactivity.
- Most antigen preparations reacted with normal human serum protein antiserum.
- Five unique antigen-antibody reactions were identified after exclusions.
Conclusions:
- Significant cross-reactivity and polyspecificity were observed in the tested antisera.
- Five novel antigen-antibody reactions were identified, potentially specific to bronchial tumors.
- Further research is required to determine the clinical utility of these newly identified antigens.